Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROLAPITANT vs ROSUVASTATIN\ROSUVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROLAPITANT vs ROSUVASTATIN\ROSUVASTATIN: Safety Overview

Metric ROLAPITANT ROSUVASTATIN\ROSUVASTATIN
Total FAERS Reports 873 557
Deaths Reported 252 13
Death Rate 28.9% 2.3%
Hospitalizations 155 170
Average Patient Age 61.4 yrs 65.7 yrs
% Female Patients 57.5% 49.6%
FDA Approval Date Oct 25, 2017 N/A
Manufacturer TerSera Therapeutics LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A